Abstract:Smyth et al. performed a 2-year randomized controlled trial (RCT) examining the impact of 6.5 h of dietary advice to reduce sodium intake on blood pressure and biological markers of cardiovascular (CVD) and renal disease.1Smyth A. Judge C. Kerins C. et al.Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials.eClinicalMedicine. 2023; 57101856Summary Full Text Full Text PDF PubMed Scopus (0) Google Scholar However, there are concerns about their methods for assessing urinary sodium and some statements regarding the feasibility of reducing dietary sodium and the evidence supporting sodium reduction. The criteria used by Smyth et al. (at least 50% predicted creatinine excretion) to assess completeness of the 24 h urine collections is unusual and would have included a large number of incomplete collections as complete (e.g., creatinine excretion of at least 60–69% of expected is only 8–49% sensitive to detect incomplete 24 h urine collections compared to the standard of PABA excretion2John K.A. Cogswell M.E. Campbell N.R. et al.Accuracy and usefulness of select methods for assessing complete collection of 24-hour urine: a systematic review.J Clin Hypertens. 2016; 18: 456-467Crossref Scopus (81) Google Scholar). We are unaware of any relevant validation study using 24 h urine creatinine within 50% of predicted. The method used to assess completeness of 24 h urines can have a more than 2-fold impact on reported sodium excretion.3Wielgosz A. Robinson C. Mao Y. et al.The impact of using different methods to assess completeness of 24-hour urine collection on estimating dietary sodium.J Clin Hypertens. 2016; 18: 581-584Crossref Scopus (37) Google Scholar To allow interpretation of sodium excretion data, Smyth et al. should use a standard method (e.g., creatinine excretion index <0.7 is the most sensitive for removing incomplete collections) and report the rates of incomplete 24 h urines at each time point where they report 24 h urine sodium excretion.2John K.A. Cogswell M.E. Campbell N.R. et al.Accuracy and usefulness of select methods for assessing complete collection of 24-hour urine: a systematic review.J Clin Hypertens. 2016; 18: 456-467Crossref Scopus (81) Google Scholar Smyth et al., do not provide adequate context when stating that “observational studies report conflicting findings on the association of low sodium intake with CVD and mortality, with some studies reporting a higher risk at low intake (<3 g/day) compared to moderate intake”, and that a recent large RCT in patients with heart failure did not report a lower risk of mortality of CVD with low sodium intake.1Smyth A. Judge C. Kerins C. et al.Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials.eClinicalMedicine. 2023; 57101856Summary Full Text Full Text PDF PubMed Scopus (0) Google Scholar Smyth et al., also state long term dietary advice studies are ineffective at reducing sodium below 3000 mg/day which contrasts with major trials of dietary advice that lowered sodium intake to less than 3000 mg/day.1Smyth A. Judge C. Kerins C. et al.Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials.eClinicalMedicine. 2023; 57101856Summary Full Text Full Text PDF PubMed Scopus (0) Google Scholar,4Campbell N.R.C. Whelton P.K. Orias M. et al.2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action.J Hum Hypertens. 2022; https://doi.org/10.1038/s41371-022-00690-0Crossref Scopus (10) Google Scholar A meta-analysis of RCTs based on dietary advice had an average reduction in sodium intake from 3646 to 2690 mg/day with a 26% reduction in CVD and a linear association of CVD with sodium intake down to 2300 mg/day.4Campbell N.R.C. Whelton P.K. Orias M. et al.2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action.J Hum Hypertens. 2022; https://doi.org/10.1038/s41371-022-00690-0Crossref Scopus (10) Google Scholar Thus, dietary advice is feasible to lower dietary sodium below 3000 mg/day and reduces CVD. Furthermore, an analysis of cohort studies that used the recommended multiple 24 h urine collections found a linear association of sodium intake from 1846 to 5230 mg/day with CVD.4Campbell N.R.C. Whelton P.K. Orias M. et al.2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action.J Hum Hypertens. 2022; https://doi.org/10.1038/s41371-022-00690-0Crossref Scopus (10) Google Scholar The National Academies of Science, Engineering and Medicine and 75 national and international nongovernmental organizations have stated that low quality research, such as the cohort studies Smyth et al. cited as showing higher CVD with lower sodium intake, are a driver of the controversy regarding the health benefits of reducing dietary sodium and that nongovernmental organizations have also expressed concern that misinformation about dietary sodium is also a driver of controversy.1Smyth A. Judge C. Kerins C. et al.Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trials.eClinicalMedicine. 2023; 57101856Summary Full Text Full Text PDF PubMed Scopus (0) Google Scholar,4Campbell N.R.C. Whelton P.K. Orias M. et al.2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action.J Hum Hypertens. 2022; https://doi.org/10.1038/s41371-022-00690-0Crossref Scopus (10) Google Scholar, 5Cappuccio F.P. Campbell N.R.C. He F.J. et al.Sodium and health: old myths, and a controversy based on denial.Curr Nutr Rep. 2022; 11: 172-184Crossref PubMed Scopus (18) Google Scholar, 6Campbell N.R.C. He F.J. Cappuccio F.P. MacGregor G.A. Dietary sodium 'controversy'—issues and potential solutions.Cur Nutr Rep. 2021; 10: 188-199Crossref PubMed Scopus (10) Google Scholar The change in dietary sodium in the large RCT in heart failure, based on dietary advice, that Smyth et al. cited, reduced dietary sodium from 2286 to 1658 mg/day, far lower than Smyth et al. claim is not feasible and the reduction was associated with an improvement in quality of life and NYHA functional class of heart failure (although mortality was not significantly changed).7Ezekowitz J.A. Colin-Ramirez E. Ross H. et al.Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.Lancet. 2022; 399: 1391-1400Summary Full Text Full Text PDF PubMed Scopus (36) Google Scholar The study by Smyth et al. shows that in the current food environment, it is difficult for individuals to sustain lower sodium intake long-term. Thus, upstream interventions, (e.g., mandatory sodium targets for processed foods), are urgently needed and strongly recommended to improve the food system to reduce sodium intake. NRCC wrote the draft which was reviewed and revised by FJH and GAM. All authors accept responsibility for the publication. NRCC reports personal fees from Resolve to Save Lives (RTSL), the Pan American Health Organization, and the World Bank, outside the submitted work; and is an unpaid member of World Action on Salt, Sugar and Health and an unpaid consultant on dietary sodium and hypertension control to numerous governmental and non-governmental organizations. Dr Campbell chaired the International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) which is an unpaid voluntary position. Dr Campbell was on the Medical Advisory Board of Switch Health (2022–2023) and was a one-time reviewer of a joint Novartis Canada Alberta Health Services collaborative project to treat dyslipidemia. All the honoraria from Switch Health and Novartis Canada have been donated to the University of Calgary to support a community cardiovascular disease prevention recognition award. FJH is an unpaid member of Action on Salt, and World Action on Salt, Sugar and Health (WASSH). GAM is the unpaid Chair of Action on Salt, Action on Sugar, WASSH, and Blood Pressure UK. Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trialsAmong individuals with moderate sodium intake, intensive dietary counselling resulted in small short-term reductions in sodium intake and BP, but no significant effect on sodium intake, BP, or cardiorenal biomarkers at two years. Our trial suggests that it may not feasible to reduce sodium sustainably in those with a sodium intake around 3.0 g/day, through an intensive dietary counselling intervention. Full-Text PDF Open AccessResponse to letter by Campbell et al. regarding the results of the COSTICK trialWe thank Cambpell et al. for taking the time to read our trial report1 and pleased to respond to their comments and queries.2 Full-Text PDF Open Access

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials

P1691Impact of dose and duration of dietary salt reduction on blood pressure levels: systematic review and meta-analysis of randomised trials

Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride.

Urinary Sodium Excretion, Blood Pressure, Cardiovascular Disease, and Mortality: a Community-Level Prospective Epidemiological Cohort Study.

24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.

Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials

Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial

Effect of Modest Salt Reduction on Blood Pressure: a Meta-Analysis of Randomized Trials. Implications for Public Health

Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives.

The Association Between Serum Sodium Concentration, Hypertension and Primary Cardiovascular Events: a Retrospective Cohort Study

Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial

Blood Pressure-Lowering Medications, Sodium Reduction, and Blood Pressure

Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH-Sodium Trial

Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial

Dietary Sodium Intake: Scientific Basis for Public Policy

DOSE-RESPONSE EFFECT OF SODIUM REDUCTION ON BLOOD PRSSURE IN TREATED HYPERTENSIVES: A SYSTEMATIC REVIEW AND INSTRUMENTAL VARIABLE META-ANALYSIS

Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial

Sodium Reduction, Mirna Profiling and CVD Risk in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial.

Dietary Counseling to Reduce Moderate Sodium Intake. Concerns about the Methods, Evidence and Feasibility of Lowering Sodium Intake

Sex modifies association between dietary sodium intake and cardiovascular disease mortality among US adult with hypertension: a national population-based cohort